Literature DB >> 15403625

The fate of antipyrine in man.

B B BRODIE, J AXELROD.   

Abstract

Entities:  

Keywords:  ANTIPYRINE

Mesh：

Substances：

Year:  1950        PMID： 15403625

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  73 in total

1.  Drug metabolism in malnourished children: a study with antipyrine.

Authors:  M Homeida; Z A Karrar; C J Roberts
Journal:  Arch Dis Child       Date:  1979-04       Impact factor: 3.791

2.  [On the demonstration of the active substances of saridon].

Authors:  F SCHEIBL; H WACHTER
Journal:  Arch Toxikol       Date:  1960

Review 3.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

4.  Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction.

Authors:  G W Hepner; E S Vesell
Journal:  Am J Dig Dis       Date:  1975-01

5.  Interactions between nutritional factors and drug biotransformations in man.

Authors:  A P Alvares; K E Anderson; A H Conney; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

6.  Disposition of antipyrine in patients with extensive metastatic liver disease.

Authors:  G M Robertz-Vaupel; K D Lindecken; T Edeki; C Funke; S Belwon; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

8.  Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.

Authors:  M Homeida; C J Roberts; M Halliwell; A E Read; R A Branch
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

9.  Antipyrine disposition and liver size in the elderly.

Authors:  C G Swift; M Homeida; M Halliwell; C J Roberts
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

10.  Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.

Authors:  D Fabre; F Bressolle; R Goméni; O Bouvet; A Dubois; C Raffanel; J C Gris; M Galtier
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.